These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 18801766

  • 1. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Br J Ophthalmol; 2009 Feb; 93(2):150-4. PubMed ID: 18801766
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.
    Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.
    Br J Ophthalmol; 2009 Apr; 93(4):448-51. PubMed ID: 19091851
    [Abstract] [Full Text] [Related]

  • 4. Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: short-term results.
    Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Ares S, Lopez-Lopez F, Rodriguez M, Fernandez M.
    Eye (Lond); 2009 Feb; 23(2):334-8. PubMed ID: 18064056
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K, Ohno-Matsui K, Teramukai S, Shimada N, Moriyama M, Hayashi W, Yoshida T, Tokoro T, Mochizuki M.
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.
    Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.
    Am J Ophthalmol; 2009 Jan; 147(1):84-93.e1. PubMed ID: 18774547
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.
    Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS.
    Br J Ophthalmol; 2007 Feb; 91(2):157-60. PubMed ID: 16870653
    [Abstract] [Full Text] [Related]

  • 9. Multifocal electroretinography and optical coherence tomography changes after repeated intravitreal bevacizumab (Avastin) in myopic choroidal neovascularization.
    Sabry D, Gad MA, Enam KM.
    Retina; 2013 Mar; 33(3):598-605. PubMed ID: 23064427
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P, Parodi MB, Papayannis A, Kontadakis S, Sheth S, Bandello F.
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [Abstract] [Full Text] [Related]

  • 11. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.
    Ruiz-Moreno JM, Montero JA, Arias L, Araiz J, Gomez-Ulla F, Silva R, Piñero DP.
    Retina; 2010 Oct; 30(10):1609-15. PubMed ID: 20856171
    [Abstract] [Full Text] [Related]

  • 12. Different dosing of intravitreal bevacizumab for choroidal neovascularization because of pathologic myopia.
    Wakabayashi T, Ikuno Y, Gomi F.
    Retina; 2011 May; 31(5):880-6. PubMed ID: 21242860
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
    [Abstract] [Full Text] [Related]

  • 14. Choroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab--a randomized controlled trial.
    Gharbiya M, Giustolisi R, Allievi F, Fantozzi N, Mazzeo L, Scavella V, Gabrieli CB.
    Am J Ophthalmol; 2010 Mar; 149(3):458-64.e1. PubMed ID: 20172072
    [Abstract] [Full Text] [Related]

  • 15. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.
    BMC Ophthalmol; 2007 Jun 07; 7():10. PubMed ID: 17555600
    [Abstract] [Full Text] [Related]

  • 16. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
    Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y.
    Am J Ophthalmol; 2009 Oct 07; 148(4):584-590.e2. PubMed ID: 19541288
    [Abstract] [Full Text] [Related]

  • 17. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
    Scupola A, Tiberti AC, Sasso P, Savastano MC, Mastrocola A, Marangoni D, Minnella AM, Falsini B, Balestrazzi E.
    Retina; 2010 May 07; 30(5):739-47. PubMed ID: 20038860
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia.
    Wakabayashi T, Ikuno Y, Gomi F, Hamasaki T, Tano Y.
    Am J Ophthalmol; 2009 Oct 07; 148(4):591-596.e1. PubMed ID: 19589497
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal bevacizumab for extrafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB, Iacono P, Papayannis A, Kontadakis S, Cascavilla ML, Zucchiatti I, Bandello F.
    Retina; 2013 Mar 07; 33(3):593-7. PubMed ID: 23190919
    [Abstract] [Full Text] [Related]

  • 20. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Ng DS, Kwok AK, Tong JM, Chan CW, Li WW.
    Retina; 2015 Dec 07; 35(12):2457-68. PubMed ID: 26035400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.